中文English
中文English

Abuout US

Abuout US

Xiamen  is a biotechnology Co., Ltd., located in Haicang District, Xiamen  Biological Medicine Industrial Park, is a commitment to the field of  rapid diagnostic reagents, research and development, production and  sales as one of the biological high-tech enterprises in Fujian, "Hundred  Talents Program" Xiamen City, "double hundred plan" settled in enterprises, with the national high-tech enterprise qualification of the company. The company is "Xiamen City," Thirteen Five "biomedical and health  industry development planning" key support enterprises, is the national  share transfer system for small and medium enterprises (new board)  listed companies.
        GMP plant with international standards, and has passed the national in  vitro diagnostic reagents quality standards and the EU industry quality  management system standard ISO13485 / 9001 certification.
       Has obtained 10 core technology patents, including 5 invention patent, 5 utility model patent certificate.
       At the same time with the Chinese Academy of Sciences to carry out  research and development cooperation, build a "joint laboratory medical  diagnosis and application of technology" to create a platform for  research and development cooperation.
      Not  only has a mature colloidal gold, latex and fluorescence quantitative  three major immunochromatographic technology platform. At present can produce products including 5 major series of about 50 kinds of products. Also has a mature molecular diagnostic product technology platform  that can produce large intestinal cancer markers and other testing  products.
        The company introduced innovative team to develop microfluidic technology platform.
        The  company has "focused on the diagnosis of science and technology to  improve the quality of life," for the purpose, to build in vitro  diagnostic reagents technology and market integration platform for the  development of new rapid diagnostic reagents and equipment to meet  market demand, continuous innovation and progress and continuously  improve the detection of disease , Prevention and treatment level, to protect the lives and health of the general public.